| 1 | Obesity (10.26442/20751753.2021.4.200832) | Abstract References ORCID License | 185.73 | 71 |
| 2 | Personalized medicine: clinical pharmacologist’s opinion (10.26442/2075-1753_2017.19.1.61-68) | Abstract References ORCID License | 132.22 | 20 |
| 3 | Covid-19: a respiratory infection caused by new coronavirus:… (10.26442/20751753.2020.3.200092) | Abstract References ORCID License | 125.53 | 17 |
| 4 | Insomnia: origins, treatment and clinical vignettes (10.26442/20751753.2020.2.200101) | Abstract References ORCID License | 107.92 | 11 |
| 5 | Management of treatment on the basis of adherence (10.26442/20751753.2020.5.200078) | Abstract References ORCID License | 107.92 | 11 |
| 6 | Fractalkin and cardiovascular disease (10.26442/20751753.2020.5.200186) | Abstract References ORCID License | 107.92 | 11 |
| 7 | Functional status of an elderly patient with diabetes (10.26442/20751753.2020.4.200156) | Abstract References ORCID License | 104.14 | 10 |
| 8 | Meldonium as a supernosological drug (10.26442/20751753.2020.5.200208) | Abstract References ORCID License | 104.14 | 10 |
| 9 | Dynamics of students' knowledge in the management of patient… (10.26442/20751753.2020.3.200080) | Abstract References ORCID License | 100.00 | 9 |
| 10 | Bisphosphonates: 50 years in clinical practice (10.26442/20751753.2020.4.200102) | Abstract References ORCID License | 100.00 | 9 |
| 11 | Algorithms for the management of patients with a new corona… (10.26442/20751753.2020.11.200520) | References ORCID License | 99.17 | 20 |
| 12 | Long COVID-19 (10.26442/20751753.2021.3.200805) | References ORCID License | 97.58 | 19 |
| 13 | Сlinical value of blood biomarker ST2 in patients with chron… (10.26442/20751753.2021.6.200606) | References ORCID License | 92.28 | 16 |
| 14 | Under-reported posterior reversible encephalopathy syndrome… (10.26442/2075-1753_2018.2.84-89) | Abstract References ORCID License | 90.31 | 7 |
| 15 | Injury of vascular endothelium and erythrocytes in COVID-19… (10.26442/20751753.2021.6.200939) | References ORCID License | 85.96 | 13 |
| 16 | Methods of cardiovascular imaging for the detection of ische… (10.26442/2075-1753_2017.19.1.18-24) | Abstract References ORCID License | 84.51 | 6 |
| 17 | Hopantenic acid: perspectives for its use in psychiatry (10.26442/2075-1753_2018.2.112-123) | Abstract References ORCID License | 84.51 | 6 |
| 18 | Rheumatoid arthritis and traditional cardiovascular risk fac… (10.26442/20751753.2020.1.200052) | Abstract References ORCID License | 84.51 | 6 |
| 19 | Asthenic syndrome in neurological and general therapeutic pr… (10.26442/20751753.2020.9.200343) | References ORCID License | 78.10 | 10 |
| 20 | A clinical case of multiple amiodarone side effects developm… (10.26442/2075-1753_2018.5.71-74) | Abstract References ORCID License | 77.82 | 5 |
| 21 | Asthma and cardiovascular disease (10.26442/2075-1753_2018.5.8-16) | Abstract References ORCID License | 77.82 | 5 |
| 22 | Management of patients with chronic heart failure and diabet… (10.26442/20751753.2020.5.200198) | Abstract References ORCID License | 77.82 | 5 |
| 23 | To the question of the use of alimamazine (Teraligen®) in pa… (10.26442/2075-1753_2018.2.145-150) | Abstract References ORCID License | 69.90 | 4 |
| 24 | Idiopathic neuralgic amyotrophy: Parsonage–Turner syndrome (10.26442/2075-1753_2018.2.78-83) | Abstract References ORCID License | 69.90 | 4 |
| 25 | Electrocardiographic predictors of sudden cardiac death (10.26442/2075-1753_2018.5.29-33) | Abstract References ORCID License | 69.90 | 4 |
| 26 | System of autonomic balance in ischemic stroke acute period… (10.26442/20751753.2020.2.200030) | Abstract References ORCID License | 69.90 | 4 |
| 27 | Viral pneumonia. radiological signs: diagnostic difficulties (10.26442/20751753.2020.3.200043) | Abstract References ORCID License | 69.90 | 4 |
| 28 | Hyperuricemia and chronic heart failure: risk factors and pr… (10.26442/20751753.2020.5.200158) | Abstract References ORCID License | 69.90 | 4 |
| 29 | Dynamic monitoring of cardiovascular diseases in patients wi… (10.26442/20751753.2020.10.200323) | References ORCID License | 67.73 | 7 |
| 30 | The role of potassium and magnesium for prevention and trea… (10.26442/20751753.2020.10.200336) | References ORCID License | 67.73 | 7 |
| 31 | Topical therapy in the treatment of patients with acute rhin… (10.26442/20751753.2021.3.200829) | References ORCID License | 67.73 | 7 |
| 32 | Changes in markers of hematological, biochemical and coagul… (10.26442/20751753.2020.11.200369) | References ORCID License | 63.38 | 6 |
| 33 | Treatment and diagnostic features of odontogenic maxillary s… (10.26442/20751753.2021.3.200702) | References ORCID License | 63.38 | 6 |
| 34 | COVID-19 and community-acquired pneumonia (10.26442/20751753.2021.3.200816) | References ORCID License | 63.38 | 6 |
| 35 | Endovascular treatment of ischemic stroke: the history of de… (10.26442/2075-1753_2017.19.1.36-41) | Abstract References ORCID License | 60.21 | 3 |
| 36 | Vertigo after traumatic brain injury: diagnostics and treatm… (10.26442/2075-1753_2018.2.151-155) | Abstract References ORCID License | 60.21 | 3 |
| 37 | Application of telemedicine for management patients with acu… (10.26442/2075-1753_2018.2.18-23) | Abstract References ORCID License | 60.21 | 3 |
| 38 | Author's methods of kinesitherapy in neurorehabilitation (le… (10.26442/2075-1753_2018.2.96-100) | Abstract References ORCID License | 60.21 | 3 |
| 39 | Anti-inflammatory therapy in atherosclerosis – is it a new p… (10.26442/2075-1753_2018.5.18-22) | Abstract References ORCID License | 60.21 | 3 |
| 40 | Combination of components for sustenance or improvement of e… (10.26442/20751753.2019.12.190621) | Abstract References ORCID License | 60.21 | 3 |
| 41 | Pericarditis in rheumatology: modern clinical and diagnostic… (10.26442/20751753.2020.1.200060) | Abstract References ORCID License | 60.21 | 3 |
| 42 | The role of neurotrophic therapy in the treatment of cogniti… (10.26442/20751753.2020.2.200056) | Abstract References ORCID License | 60.21 | 3 |
| 43 | A patient with an acute headache at a doctor's appointment:… (10.26442/20751753.2020.2.200068) | Abstract References ORCID License | 60.21 | 3 |
| 44 | Influence of local application of polyoxidonium on symptoms… (10.26442/20751753.2020.3.200091) | Abstract References ORCID License | 60.21 | 3 |
| 45 | Charcot diabetic neuroosteoartropathy: review of pathology a… (10.26442/20751753.2020.4.200130) | Abstract References ORCID License | 60.21 | 3 |
| 46 | Possibilities of reperfusion therapy for patients with acute… (10.26442/20751753.2020.5.200182) | Abstract References ORCID License | 60.21 | 3 |
| 47 | Cardiology: genetics’ time (10.26442/20751753.2020.5.200185) | Abstract References ORCID License | 60.21 | 3 |
| 48 | Pharmacoeconomic analysis of the use of dapagliflozin in pat… (10.26442/20751753.2020.10.200349) | References ORCID License | 58.36 | 5 |
| 49 | Favipiravir as a potential countermeasure for COVID-19 (10.26442/20751753.2020.11.200368) | References ORCID License | 58.36 | 5 |
| 50 | Differential diagnosis of acute tonsillopharyngitis (10.26442/20751753.2020.11.200422) | References ORCID License | 58.36 | 5 |